Predictive Modeling of Mortality in Polymyositis/Dermatomyositis Patients with Interstitial Lung Disease Based on Combination of Serum Myositis-Specific Autoantibodies and Conventional Biomarkers

被引：0

作者：

Gono, Takahisa ^{[1
]}

Masui, Kenichi ^{[2
]}

Kawaguchi, Yasushi ^{[3
]}

Ikeda, Kei ^{[4
]}

Kawakami, Atsushi ^{[5
]}

Tamura, Maasa ^{[6
]}

Tanino, Yoshinori ^{[7
]}

Nunokawa, Takahiro ^{[8
]}

Kaneko, Yuko ^{[9
]}

Sato, Shinji ^{[10
]}

Asakawa, Katsuaki ^{[11
]}

Nishina, Naoshi ^{[9
]}

Kuwana, Masataka ^{[1
]}

机构：

[1] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan

[2] Natl Def Med Coll, Sch Med, Dept Anesthesiol, Tokorozawa, Saitama, Japan

[3] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan

[4] Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan

[5] Nagasaki Univ, Div Adv Prevent Med Sci, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, Nagasaki, Japan

[6] Yokohama City Univ, Dept Stem Cell & Immune Regulat, Grad Sch Med, Yokohama, Kanagawa, Japan

[7] Fukushima Med Univ, Dept Pulm Med, Sch Med, Fukushima, Japan

[8] Tokyo Metropolitan Tama Med Ctr, Dept Rheumat Dis, Tokyo, Japan

[9] Keio Univ, Div Rheumatol, Dept Internal Med, Sch Med, Tokyo, Japan

[10] Tokai Univ, Dept Internal Med, Div Rheumatol, Sch Med, Isehara, Kanagawa, Japan

[11] Niigata Univ Med & Dent Hosp, Div Resp Med, Niigata, Japan

来源：

ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 47 条

[41] Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
Kang, Eun Ha
Nakashima, Ran
Mimori, Tsuneyo
Kim, Jinhyun
Lee, Yun Jong
Lee, Eun Bong
Song, Yeong Wook
BMC MUSCULOSKELETAL DISORDERS, 2010, 11
[42] MORTALITY RISK STRATIFICATION USING CLUSTER ANALYSIS IN PATIENTS WITH MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE RECEIVING INITIAL TRIPLE COMBINATION THERAPY
Gono, Takahisa
Masui, Kenichi
Sato, Shinji
Kuwana, Masataka
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 491 - 491
[43] Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
Gono, Takahisa
Masui, Kenichi
Sato, Shinji
Kuwana, Masataka
FRONTIERS IN MEDICINE, 2022, 9
[44] HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients
Zou, Jing
Guo, Qiang
Chi, Jiachang
Wu, Huawei
Bao, Chunde
CLINICAL RHEUMATOLOGY, 2015, 34 (04) : 707 - 714
[45] HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients
Jing Zou
Qiang Guo
Jiachang Chi
Huawei Wu
Chunde Bao
Clinical Rheumatology, 2015, 34 : 707 - 714
[46] CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/dermatomyositis
Wong, RCW
Klingberg, S
Wilson, R
JOURNAL OF RHEUMATOLOGY, 2002, 29 (09) : 2021 - 2022
[47] CA15-3 and cancer associated serum antigen assays are alternatives to the KL-6 assay for measuring serum MUC-1 levels in patients with interstitial lung disease associated with polymyositis/dermatomyositis - Drs. Harigai and Kamatani reply
Harigai, M
Nakaji, H
Kamatani, N
JOURNAL OF RHEUMATOLOGY, 2002, 29 (09) : 2022 - 2022

← 1 2 3 4 5 →